Roberto, Aaron J.Lorenzo, AileenLi, KevinYoung, JonathanMohan, AbhishekPinnaka, SubhashLapidus, Kyle A. B.2016-08-092016Roberto, Aaron J., Aileen Lorenzo, Kevin J. Li, Jonathan Young, Abhishek Mohan, Subhash Pinnaka, and Kyle A. B. Lapidus. 2016. “First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone.” Case Reports in Psychiatry 2016 (1): 7257489. doi:10.1155/2016/7257489. http://dx.doi.org/10.1155/2016/7257489.2090-682Xhttp://nrs.harvard.edu/urn-3:HUL.InstRepos:27822163Synthetic cannabinoids- (SCs-) induced psychosis is a growing public health concern. It leads to significant impairment, including emotional distress, difficulty communicating, and other debilitating symptoms. In this case report, we discuss a patient with no previous history of psychotic symptoms, presenting with first-episode psychosis in the context of progressive, acutely worsening, disorganized, psychotic thoughts and behaviors following prolonged use of SCs. We also discuss relevant literature on SCs-induced psychosis, highlighting its prevalence, presentation, diagnosis, and recommended management. It is important to diagnose and treat SCs-induced psychosis as early and efficiently as possible, in order to alleviate symptoms while limiting functional impairment and emotional distress to the patient.en-USJournal Article2016-08-0910.1155/2016/7257489